GRDN

Over the past six months (March 2026 - September 2026), Guardian Pharmacy Services' stock (GRDN) experienced several notable events. The company expanded its network through strategic acquisitions, including Nautilus Pharmacy in Tennessee and Wellness Concepts in Virginia. Guardian reported strong financial results, with second-quarter 2026 earnings beating analyst expectations, leading to an 11.05% daily stock increase on August 7, 2026, after raising its full-year guidance. Q1 2026 revenue was $336.6 million with a net income of approximately $13.5 million, and adjusted EPS of $0.29, surpassing estimates. While Wall Street Zen downgraded the stock to "Hold," the overall analyst consensus remains a "Moderate Buy," with several firms raising price targets or upgrading ratings, and the stock showing a robust 1-year performance of +70.3%. Guardian Pharmacy Services was added to the Russell 2000 Defensive Index and the Russell 2000 Growth Defensive Index on September 20, 2026. Leadership changes included David Morris transitioning to Chief Operating Officer and Will Mudd being appointed Chief Financial Officer, both effective July 1, 2026. Shareholder activity involved Bindley Capital Partners I, LLC selling 3,570,677 shares of Class A Common Stock and converting 6,100,175 shares of Class B Common Stock into Class A Common Stock in March 2026, with new lock-up agreements for major holders effective through June 30, 2026.